(Q45251420)

11 December 2017

title

Engineering the assemblies of biomaterial nanocarriers for delivery of multiple theranostic agents with enhanced antitumor efficacy (English)

1 reference

11 December 2017

1 reference

4

1 reference

11 December 2017

Hai Wang

1

1 reference

11 December 2017

Yan Wu

series ordinal

2

1 reference

11 December 2017

Ruifang Zhao

series ordinal

3

1 reference

11 December 2017

language of work or name

English

0 references

publication date

22 January 2013

1 reference

11 December 2017

1 reference

11 December 2017

volume

25

1 reference

11 December 2017

issue

11

1 reference

11 December 2017

page(s)

1616-1622

1 reference

Synergistic drug combinations tend to improve therapeutically relevant selectivity

11 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201204750

Multidrug nanoparticles based on novel random copolymer containing cytarabine and fluorodeoxyuridine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201204750

Engineering of self-assembled nanoparticle platform for precisely controlled combination drug therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201204750

The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201204750

Superior survival with capecitabine plus docetaxel combination therapy in anthracycline-pretreated patients with advanced breast cancer: phase III trial results

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201204750

Harnessing structure-activity relationship to engineer a cisplatin nanoparticle for enhanced antitumor efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201204750

Co-delivery of drugs and DNA from cationic core-shell nanoparticles self-assembled from a biodegradable copolymer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201204750

Co-delivery of siRNA and an anticancer drug for treatment of multidrug-resistant cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201204750

Nanoparticle-mediated targeting of MAPK signaling predisposes tumor to chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201204750

Toxic potential of materials at the nanolevel

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201204750

Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201204750

The use of submicron/nanoscale PLGA implants to deliver paclitaxel with enhanced pharmacokinetics and therapeutic efficacy in intracranial glioblastoma in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201204750

Controlled release of growth hormone from thermosensitive triblock copolymer systems: In vitro and in vivo evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201204750

Control of foodborne pathogens on ready-to-eat roast beef slurry by epsilon-polylysine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201204750

Nanoscale double emulsions stabilized by single-component block copolypeptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201204750

Effect of concentration on the cytotoxic mechanism of doxorubicin--apoptosis and oxidative DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201204750

Mechanism-based pharmacokinetic model for paclitaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201204750

Protein-directed synthesis of highly fluorescent gold nanoclusters

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201204750

Isolation and Metastatic Properties of Detachment Variants of 816 Melanoma Cells 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201204750

Sensitization of B16 tumor cells with a CXCR4 antagonist increases the efficacy of immunotherapy for established lung metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201204750

Inhibition of experimental lung metastasis by aerosol delivery of PEI-p53 complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201204750

Mechanism of doxorubicin-induced inhibition of sarcoplasmic reticulum Ca(2+)-ATPase gene transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201204750

Pharmacogenomics--drug disposition, drug targets, and side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201204750

Targeted delivery of a cisplatin prodrug for safer and more effective prostate cancer therapy in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201204750

Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201204750

Visual evidence of acidic environment within degrading poly(lactic-co-glycolic acid) (PLGA) microspheres

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201204750

?-Poly-l-lysine: microbial production, biodegradation and application potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201204750

21 January 2018

Identifiers

DOI

10.1002/ADMA.201204750

1 reference

11 December 2017

1 reference